Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Metformin or Furosemide on Rosuvastatin PK
NCT02574845Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2015
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia (6 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Curve of Rosuvastatin From 0 to the Last Quantifiable Data Point and Maximum Concentration of Rosuvastatin. Started Oct 2015; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02574845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02574845.